|
PSNL | Personalis, Inc. |
|
|
PSNL | Personalis, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.92 |
| Leverage | 30.48% |
| Market Cap | $ 181.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -90.5m |
| Margin | -140.18% |
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.